Please assess the completion status of the following clinical trial:

Trial Title: Sublingual Misoprostol for Induction of Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Indication for labour induction~* Term pregnancy with alive fetus~* Bishop score less than six~Exclusion Criteria:~* Previous uterine scar~* Nonvertex presentation~* Non-reassuring fetal status~* Fetal anomalies~* Fetal growth restriction~* Genital bleeding~* Tumors, malformations and/or ulcers of vulva, perineum or vagina

- Gender: FEMALE
- Minimum Age: 15 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Sublingual Misoprostol 12,5mcg (Type: ACTIVE_COMPARATOR): Sublingual misoprostol or placebo tablete will be administered for each six hours until the maximum dose of 100mcg or eight tablets.
- Vaginal Misoprostol 25 mcg (Type: ACTIVE_COMPARATOR): Vaginal misoprostol or placebo tablets will be administered for each six hours until the maximum dose of 200mcg or eight tablets. Each pacient will receve at the same time a sublingual placebo tablet and vaginal misoprostol or sublingual misoprostol and vaginal placebo tablet. It will depend of the randomization.

Based on this trial design, predict the completion outcome and termination type (if applicable).